These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8692978

  • 1. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family.
    Su ZZ, Lin J, Shen R, Fisher PE, Goldstein NI, Fisher PB.
    Proc Natl Acad Sci U S A; 1996 Jul 09; 93(14):7252-7. PubMed ID: 8692978
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene.
    Gopalkrishnan RV, Roberts T, Tuli S, Kang D, Christiansen KA, Fisher PB.
    Oncogene; 2000 Sep 07; 19(38):4405-16. PubMed ID: 10980616
    [Abstract] [Full Text] [Related]

  • 3. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.
    Shen R, Su ZZ, Olsson CA, Fisher PB.
    Proc Natl Acad Sci U S A; 1995 Jul 18; 92(15):6778-82. PubMed ID: 7542776
    [Abstract] [Full Text] [Related]

  • 4. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
    Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.
    Gene; 2001 Nov 14; 279(1):17-31. PubMed ID: 11722842
    [Abstract] [Full Text] [Related]

  • 5. Expression of the prostate-specific membrane antigen.
    Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD.
    Cancer Res; 1994 Apr 01; 54(7):1807-11. PubMed ID: 7511053
    [Abstract] [Full Text] [Related]

  • 6. Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line.
    Zhou Y, Toth M, Hamman MS, Monahan SJ, Lodge PA, Boynton AL, Salgaller ML.
    Biochem Biophys Res Commun; 2002 Jan 18; 290(2):830-8. PubMed ID: 11785977
    [Abstract] [Full Text] [Related]

  • 7. Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein.
    Naz RK, Santhanam R, Tyagi N.
    Biochem Biophys Res Commun; 2002 Oct 11; 297(5):1075-84. PubMed ID: 12372395
    [Abstract] [Full Text] [Related]

  • 8. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
    Shen R, Su ZZ, Olsson CA, Goldstein NI, Fisher PB.
    J Natl Cancer Inst; 1994 Jan 19; 86(2):91-8. PubMed ID: 7505832
    [Abstract] [Full Text] [Related]

  • 9. Galectin-8. A new rat lectin, related to galectin-4.
    Hadari YR, Paz K, Dekel R, Mestrovic T, Accili D, Zick Y.
    J Biol Chem; 1995 Feb 17; 270(7):3447-53. PubMed ID: 7852431
    [Abstract] [Full Text] [Related]

  • 10. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.
    Chen MW, Vacherot F, De La Taille A, Gil-Diez-De-Medina S, Shen R, Friedman RA, Burchardt M, Chopin DK, Buttyan R.
    Oncogene; 2002 Nov 07; 21(51):7861-71. PubMed ID: 12420223
    [Abstract] [Full Text] [Related]

  • 11. Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas.
    Chen PF, Freedman RS, Chernajovsky Y, Platsoucas CD.
    Hum Antibodies Hybridomas; 1994 Nov 07; 5(3-4):131-42. PubMed ID: 7756578
    [Abstract] [Full Text] [Related]

  • 12. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
    An G, Ng AY, Meka CS, Luo G, Bright SP, Cazares L, Wright GL, Veltri RW.
    Cancer Res; 2000 Dec 15; 60(24):7014-20. PubMed ID: 11156405
    [Abstract] [Full Text] [Related]

  • 13. CTp11, a novel member of the family of human cancer/testis antigens.
    Zendman AJ, Cornelissen IM, Weidle UH, Ruiter DJ, van Muijen GN.
    Cancer Res; 1999 Dec 15; 59(24):6223-9. PubMed ID: 10626816
    [Abstract] [Full Text] [Related]

  • 14. Surface-epitope masking (SEM): an immunological subtraction approach for developing monoclonal antibodies targeting surface-expressed molecules.
    Goldstein NI, Fisher PB.
    Methods Mol Biol; 2007 Dec 15; 383():245-58. PubMed ID: 18217690
    [Abstract] [Full Text] [Related]

  • 15. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
    Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB.
    Cancer Res; 1999 Jul 01; 59(13):3192-8. PubMed ID: 10397265
    [Abstract] [Full Text] [Related]

  • 16. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples.
    Sun Y, Lin J, Katz AE, Fisher PB.
    Cancer Res; 1997 Jan 01; 57(1):18-23. PubMed ID: 8988032
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype.
    Ellerhorst J, Nguyen T, Cooper DN, Lotan D, Lotan R.
    Int J Oncol; 1999 Feb 01; 14(2):217-24. PubMed ID: 9917495
    [Abstract] [Full Text] [Related]

  • 18. Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line.
    Chang K, Pastan I.
    Int J Cancer; 1994 Apr 01; 57(1):90-7. PubMed ID: 8150545
    [Abstract] [Full Text] [Related]

  • 19. D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer.
    Weigle B, Kiessling A, Ebner R, Fuessel S, Temme A, Meye A, Schmitz M, Rieger MA, Ockert D, Wirth MP, Rieber EP.
    Int J Cancer; 2004 May 10; 109(6):882-92. PubMed ID: 15027122
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.
    De Backer O, Arden KC, Boretti M, Vantomme V, De Smet C, Czekay S, Viars CS, De Plaen E, Brasseur F, Chomez P, Van den Eynde B, Boon T, van der Bruggen P.
    Cancer Res; 1999 Jul 01; 59(13):3157-65. PubMed ID: 10397259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.